{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:19:27Z","timestamp":1778887167442,"version":"3.51.4"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ho Chi Minh City University of Industry and Trade","award":["46\/H\u0110-DCT"],"award-info":[{"award-number":["46\/H\u0110-DCT"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Protein J"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s10930-024-10188-y","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T04:50:56Z","timestamp":1710478256000},"page":"159-170","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Immunosuppressive Cyclotides: A Promising Approach for Treating Autoimmune Diseases"],"prefix":"10.1007","volume":"43","author":[{"given":"Nguyen Thai","family":"Huynh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9969-1846","authenticated-orcid":false,"given":"Thao N.T","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8066-4504","authenticated-orcid":false,"given":"Yen N.D.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le Hang","family":"Dang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Son H.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3500-5958","authenticated-orcid":false,"given":"Tien T.","family":"Dang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,15]]},"reference":[{"issue":"9270","key":"10188_CR1","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/S0140-6736(00)04904-7","volume":"357","author":"J Parkin","year":"2001","unstructured":"Parkin J, Cohen B (2001) An overview of the immune system. Lancet 357(9270):1777\u20131789","journal-title":"Lancet"},{"issue":"8","key":"10188_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41581-023-00720-1","volume":"19","author":"DS Pisetsky","year":"2023","unstructured":"Pisetsky DS (2023) Pathogenesis of autoimmune disease. Nat Rev Nephrol 19(8):509\u2013524","journal-title":"Nat Rev Nephrol"},{"key":"10188_CR3","doi-asserted-by":"crossref","unstructured":"Kellie S, Al-Mansour Z Chapter Four - Overview of the immune system, in: M. Skwarczynski, I. Toth (Eds.), Micro and nanotechnology in vaccine development, William Andrew Publishing2017, pp. 63\u201381","DOI":"10.1016\/B978-0-323-39981-4.00004-X"},{"issue":"5","key":"10188_CR4","first-page":"340","volume":"345","author":"A Davidson","year":"2001","unstructured":"Davidson A, Diamond B (2001) Autoimmune Dis NEJM 345(5):340\u2013350","journal-title":"Autoimmune Dis NEJM"},{"issue":"6","key":"10188_CR5","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1136\/annrheumdis-2019-216794","volume":"80","author":"S Akari","year":"2021","unstructured":"Akari S, Matteo Maurizio G, Kazuhiko Y (2021) Functional genomics of autoimmune diseases. Ann Rheum Dis 80(6):689","journal-title":"Ann Rheum Dis"},{"issue":"2 Suppl 2","key":"10188_CR6","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jaci.2009.12.980","volume":"125","author":"DD Chaplin","year":"2010","unstructured":"Chaplin DD (2010) Overview of the immune response. J Allergy Clin Immunol 125(2 Suppl 2):S3\u201323","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10188_CR7","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/joim.12395","volume":"278","author":"L Wang","year":"2015","unstructured":"Wang L, Wang F-S, Gershwin ME (2015) Human autoimmune diseases: a comprehensive update. J Intern Med 278(4):369\u2013395","journal-title":"J Intern Med"},{"key":"10188_CR8","doi-asserted-by":"crossref","unstructured":"Musette P, Bouaziz JD (2018) B cell modulation strategies in autoimmune diseases: new concepts. Front Immunol 9","DOI":"10.3389\/fimmu.2018.00622"},{"key":"10188_CR9","doi-asserted-by":"crossref","unstructured":"Petersone L, Edner NM, Ovcinnikovs V, Heuts F, Ross EM, Ntavli E, Wang CJ, Walker LSK (2018) T cell\/B cell collaboration and autoimmunity: an intimate relationship. Front Immunol 9","DOI":"10.3389\/fimmu.2018.01941"},{"issue":"16","key":"10188_CR10","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMra050541","volume":"353","author":"T Rhen","year":"2005","unstructured":"Rhen T, Cidlowski JA (2005) Antiinflammatory action of glucocorticoids \u2014 new mechanisms for old drugs. NEJM 353(16):1711\u20131723","journal-title":"NEJM"},{"issue":"6116","key":"10188_CR11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1126\/science.1230720","volume":"339","author":"I Tabas","year":"2013","unstructured":"Tabas I, Glass CK (2013) Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science 339(6116):166\u2013172","journal-title":"Science"},{"issue":"1","key":"10188_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/intimm\/dxu102","volume":"27","author":"C Monaco","year":"2015","unstructured":"Monaco C, Nanchahal J, Taylor P, Feldmann M (2015) Anti-TNF therapy: past, present and future. Int Immunol 27(1):55\u201362","journal-title":"Int Immunol"},{"issue":"1","key":"10188_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41573-020-0082-8","volume":"20","author":"AA Zarrin","year":"2021","unstructured":"Zarrin AA, Bao K, Lupardus P, Vucic D (2021) Kinase inhibition in autoimmunity and inflammation. Nat Rev Drug Discov 20(1):39\u201363","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"10188_CR14","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nrd.2017.201","volume":"16","author":"DM Schwartz","year":"2017","unstructured":"Schwartz DM, Kanno Y, Villarino A, Ward M, Gadina M (2017) O\u2019Shea, JAK inhibition as a therapeutic strategy for immune and inflammatory diseases. Nat Rev Drug Discov 16(12):843\u2013862","journal-title":"Nat Rev Drug Discov"},{"key":"10188_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2147\/DDDT.S32687","volume":"7null","author":"JWL Brown","year":"2013","unstructured":"Brown JWL, Coles AJ (2013) Alemtuzumab: evidence for its potential in relapsing\u2014remitting multiple sclerosis. Drug Des Devel Ther 7null:131\u2013138","journal-title":"Drug Des Devel Ther"},{"issue":"9","key":"10188_CR16","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1136\/ard.2005.046938","volume":"65","author":"HU Scherer","year":"2006","unstructured":"Scherer HU, Burmester GR, Riemekasten G (2006) Targeting activated T cells: successful use of anti-CD25 monoclonal antibody basiliximab in a patient with systemic sclerosis. Ann Rheum Dis 65(9):1245","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10188_CR17","first-page":"269","volume":"147","author":"L Lunardon","year":"2012","unstructured":"Lunardon L, Payne AS (2012) Rituximab for autoimmune blistering diseases: recent studies, new insights. G Ital Dermatol Venereol 147(3):269\u2013276","journal-title":"G Ital Dermatol Venereol"},{"issue":"1","key":"10188_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2174\/1872213X12666180115153635","volume":"12","author":"MI Yatoo","year":"2018","unstructured":"Yatoo MI, Gopalakrishnan A, Saxena A, Parray OR, Tufani NA, Chakraborty S, Tiwari R, Dhama K, Iqbal HMN (2018) Anti-inflammatory drugs and herbs with special emphasis on herbal medicines for countering inflammatory diseases and disorders - a review. Recent Pat Inflamm Allergy Drug Discov 12(1):39\u201358","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"issue":"33","key":"10188_CR19","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.2174\/0929867323666160817163531","volume":"23","author":"KB Dar","year":"2016","unstructured":"Dar KB, Bhat AH, Amin S, Masood A, Zargar MA (2016) Ganie, inflammation: a multidimensional insight on natural anti-inflammatory therapeutic compounds. Curr Med Chem 23(33):3775\u20133800","journal-title":"Curr Med Chem"},{"issue":"24","key":"10188_CR20","doi-asserted-by":"publisher","first-page":"12375","DOI":"10.1021\/acs.chemrev.9b00402","volume":"119","author":"SJ de Veer","year":"2019","unstructured":"de Veer SJ, Kan M-W, Craik DJ (2019) Cyclotides: from structure to function. Chem Rev 119(24):12375\u201312421","journal-title":"Chem Rev"},{"issue":"14","key":"10188_CR21","first-page":"1350","volume":"18","author":"A Gould","year":"2017","unstructured":"Gould A, Camarero JA (2017) Cyclotides: overview and biotechnological applications. Chem Biochem 18(14):1350\u20131363","journal-title":"Chem Biochem"},{"key":"10188_CR22","doi-asserted-by":"crossref","unstructured":"Jacob B, Vogelaar A, Cadenas E, Camarero JA (2022) Using the cyclotide scaffold for targeting biomolecular interactions in drug development. Molecules 27(19)","DOI":"10.3390\/molecules27196430"},{"key":"10188_CR23","doi-asserted-by":"crossref","unstructured":"Wang KQ, Chiche CK, Craik L (2008) DJ CyBase: a database of cyclic protein sequences and structures, with applications in protein discovery and engineering, Nucleic Acids Res D206-10","DOI":"10.1093\/nar\/gkm953"},{"key":"10188_CR24","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3389\/fpls.2019.00645","volume":"10","author":"GK Oguis","year":"2019","unstructured":"Oguis GK, Gilding EK, Jackson MA, Craik DJ (2019) Butterfly pea (Clitoria ternatea), a cyclotide-bearing plant with applications in agriculture and medicine. Front Plant Sci 10:645","journal-title":"Front Plant Sci"},{"issue":"9","key":"10188_CR25","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1105\/tpc.108.062331","volume":"20","author":"CW Gruber","year":"2008","unstructured":"Gruber CW, Elliott AG, Ireland DC, Delprete PG, Dessein S, G\u00f6ransson U, Trabi M, Wang CK, Kinghorn AB, Robbrecht E, Craik DJ (2008) Distribution and evolution of circular miniproteins in flowering plants. Plant Cell 20(9):2471\u20132483","journal-title":"Plant Cell"},{"issue":"4","key":"10188_CR26","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1021\/np100790f","volume":"74","author":"MY Yeshak","year":"2011","unstructured":"Yeshak MY, Burman R, Asres K, G\u00f6ransson U (2011) Cyclotides from an extreme habitat: characterization of cyclic peptides from Viola Abyssinica of the Ethiopian highlands. J Nat Prod 74(4):727\u2013731","journal-title":"J Nat Prod"},{"issue":"7","key":"10188_CR27","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1021\/acs.accounts.7b00157","volume":"50","author":"SJ de Veer","year":"2017","unstructured":"de Veer SJ, Weidmann J, Craik DJ (2017) Cyclotides as tools in chemical biology. Acc Chem Res 50(7):1557\u20131565","journal-title":"Acc Chem Res"},{"issue":"6","key":"10188_CR28","doi-asserted-by":"publisher","first-page":"e24284","DOI":"10.1002\/pep2.24284","volume":"114","author":"TT Dang","year":"2022","unstructured":"Dang TT, Harvey PJ, Chan LY, Huang Y-H, Kaas Q, Craik DJ (2022) Mutagenesis of cyclotide Cter 27 exemplifies a robust folding strategy for bracelet cyclotides. Peptide Sci 114(6):e24284","journal-title":"Pept Sci"},{"issue":"12","key":"10188_CR29","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.1021\/jo200520v","volume":"76","author":"DJ Craik","year":"2011","unstructured":"Craik DJ, Conibear AC (2011) The chemistry of cyclotides. J Org Chem 76(12):4805\u20134817","journal-title":"J Org Chem"},{"issue":"11","key":"10188_CR30","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1021\/acschembio.1c00524","volume":"16","author":"R Hellinger","year":"2021","unstructured":"Hellinger R, Muratspahi\u0107 E, Devi S, Koehbach J, Vasileva M, Harvey PJ, Craik DJ, Gr\u00fcndemann C, Gruber CW (2021) Importance of the cyclic cystine knot structural motif for immunosuppressive effects of cyclotides. ACS Chem Biol 16(11):2373\u20132386","journal-title":"ACS Chem Biol"},{"issue":"24","key":"10188_CR31","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1002\/cbic.202000315","volume":"21","author":"TNG Handley","year":"2020","unstructured":"Handley TNG, Wang CK, Harvey PJ, Lawrence N, Craik DJ (2020) Cyclotide structures revealed by NMR, with a little help from X-ray crystallography. ChemBioChem 21(24):3463\u20133475","journal-title":"ChemBioChem"},{"issue":"13","key":"10188_CR32","doi-asserted-by":"publisher","first-page":"4147","DOI":"10.1021\/bi00013a002","volume":"34","author":"O Saether","year":"1995","unstructured":"Saether O, Craik DJ, Campbell ID, Sletten K, Juul J, Norman DG (1995) Elucidation of the primary and three-dimensional structure of the uterotonic polypeptide kalata B1. Biochemistry 34(13):4147\u20134158","journal-title":"Biochemistry"},{"issue":"20","key":"10188_CR33","doi-asserted-by":"publisher","first-page":"5965","DOI":"10.1021\/bi049711q","volume":"43","author":"ML Colgrave","year":"2004","unstructured":"Colgrave ML, Craik DJ (2004) Thermal, chemical, and enzymatic stability of the cyclotide kalata B1: the importance of the cyclic cystine knot. Biochemistry 43(20):5965\u20135975","journal-title":"Biochemistry"},{"issue":"1","key":"10188_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10989-016-9537-5","volume":"23","author":"B Senthilkumar","year":"2017","unstructured":"Senthilkumar B, Rajasekaran R (2017) Analysis of the structural stability among cyclotide members through cystine knot fold that underpins its potential use as a drug scaffold. Int J Pept Res Ther 23(1):1\u201311","journal-title":"Int J Pept Res Ther"},{"issue":"5","key":"10188_CR35","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/bip.22284","volume":"100","author":"AG Poth","year":"2013","unstructured":"Poth AG, Chan LY, Craik DJ (2013) Cyclotides as grafting frameworks for protein engineering and drug design applications. Biopolymers 100(5):480\u2013491","journal-title":"Biopolymers"},{"key":"10188_CR36","doi-asserted-by":"crossref","unstructured":"Huang YH, Du Q, Jiang Z, King GJ, Collins BM, Wang CK, Craik DJ (2021) Enabling efficient folding and high-resolution crystallographic analysis of bracelet cyclotides. Molecules 26(18)","DOI":"10.3390\/molecules26185554"},{"issue":"3","key":"10188_CR37","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/jxb\/erx422","volume":"69","author":"S Poon","year":"2018","unstructured":"Poon S, Harris KS, Jackson MA, McCorkelle OC, Gilding EK, Durek T, van der Weerden NL, Craik DJ, Anderson MA (2018) Co-expression of a cyclizing asparaginyl endopeptidase enables efficient production of cyclic peptides in planta. J Exp Bot 69(3):633\u2013641","journal-title":"J Exp Bot"},{"issue":"5","key":"10188_CR38","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1021\/acs.biochem.6b01212","volume":"56","author":"S Troeira Henriques","year":"2017","unstructured":"Troeira Henriques S, Craik DJ (2017) Cyclotide structure and function: the role of membrane binding and permeation. Biochemistry 56(5):669\u2013682","journal-title":"Biochemistry"},{"issue":"25","key":"10188_CR39","doi-asserted-by":"publisher","first-page":"22875","DOI":"10.1074\/jbc.M101666200","volume":"276","author":"ME Felizmenio-Quimio","year":"2001","unstructured":"Felizmenio-Quimio ME, Daly NL, Craik DJ (2001) Circular proteins in plants: solution structure of a novel macrocyclic trypsin inhibitor from. Momordica cochinchinensis J Biol Chem 276(25):22875\u201322882","journal-title":"Momordica cochinchinensis J Biol Chem"},{"issue":"27","key":"10188_CR40","doi-asserted-by":"publisher","first-page":"7973","DOI":"10.1021\/bi0106639","volume":"40","author":"A Heitz","year":"2001","unstructured":"Heitz A, Hernandez J-F, Gagnon J, Hong TT, Pham TTC, Nguyen TM, Le-Nguyen D, Chiche L (2001) Solution structure of the squash trypsin inhibitor MCoTI-II. A new family for cyclic knottins. Biochemistry 40(27):7973\u20137983","journal-title":"Biochemistry"},{"issue":"5","key":"10188_CR41","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2174\/1389203043379477","volume":"5","author":"L Chiche","year":"2004","unstructured":"Chiche L, Heitz A, Gelly J-C, Gracy J, Chau TTP, Ha TP, Hernandez J-F (2004) Le-Nguyen, Squash inhibitors: from structural motifs to macrocyclic knottins, Curr. Protein Pept Sci 5(5):341\u2013349","journal-title":"Protein Pept Sci"},{"issue":"2","key":"10188_CR42","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/nph.13789","volume":"210","author":"EK Gilding","year":"2016","unstructured":"Gilding EK, Jackson MA, Poth AG, Henriques ST, Prentis PJ, Mahatmanto T, Craik DJ (2016) Gene coevolution and regulation lock cyclic plant defence peptides to their targets. New Phytol 210(2):717\u2013730","journal-title":"New Phytol"},{"key":"10188_CR43","doi-asserted-by":"publisher","first-page":"104025","DOI":"10.1016\/j.jinsphys.2020.104025","volume":"122","author":"K Dancewicz","year":"2020","unstructured":"Dancewicz K, Slazak B, Kie\u0142kiewicz M, Kapusta M, Bohdanowicz J, Gabry\u015b B (2020) Behavioral and physiological effects of Viola spp. cyclotides on Myzus persicae (Sulz). J Insect Physiol 122:104025","journal-title":"J Insect Physiol"},{"issue":"6","key":"10188_CR44","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1021\/acs.jnatprod.9b01218","volume":"83","author":"TT Dang","year":"2020","unstructured":"Dang TT, Chan LY, Huang YH, Nguyen LTT, Kaas Q, Huynh T, Craik DJ (2020) Exploring the sequence diversity of cyclotides from Vietnamese Viola species. J Nat Prod 83(6):1817\u20131828","journal-title":"J Nat Prod"},{"issue":"2","key":"10188_CR45","first-page":"174","volume":"36","author":"L Gran","year":"1973","unstructured":"Gran L (1973) Oxytocic principles of Oldenlandia Affinis. Lloydia 36(2):174\u2013178","journal-title":"Lloydia"},{"issue":"5","key":"10188_CR46","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/j.1600-0773.1973.tb01541.x","volume":"33","author":"L Gran","year":"1973","unstructured":"Gran L (1973) On the effect of a polypeptide isolated from Kalata-Kalata (Oldenlandia Affinis DC) on the oestrogen dominated uterus. Acta Pharmacol Toxicol (Copenh) 33(5):400\u2013408","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"issue":"16","key":"10188_CR47","doi-asserted-by":"publisher","first-page":"8913","DOI":"10.1073\/pnas.96.16.8913","volume":"96","author":"JP Tam","year":"1999","unstructured":"Tam JP, Lu YA, Yang JL, Chiu KW (1999) An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides. Proc Natl Acad Sci U S A 96(16):8913\u20138918","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10188_CR48","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1093\/jac\/dkq220","volume":"65","author":"M Pr\u00e4nting","year":"2010","unstructured":"Pr\u00e4nting M, L\u00f6\u00f6v C, Burman R, G\u00f6ransson U, Andersson DI (2010) The cyclotide cycloviolacin O2 from Viola odorata has potent bactericidal activity against Gram-negative bacteria. J Antimicrob Chemother 65(9):1964\u20131971","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"10188_CR49","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1021\/np50114a002","volume":"57","author":"KM Witherup","year":"1994","unstructured":"Witherup KM, Bogusky MJ, Anderson PS, Ramjit H, Ransom RW, Wood T, Sardana M (1994) Cyclopsychotride A, a biologically active, 31-residue cyclic peptide isolated from Psychotria longipes. J Nat Prod 57(12):1619\u20131625","journal-title":"J Nat Prod"},{"key":"10188_CR50","doi-asserted-by":"crossref","unstructured":"Gustafson KR, Sowder RC, II LE, Henderson IC, Parsons Y, Kashman JH, Cardellina II, McMahon JB, Buckheit RW Jr., Pannell LK, Boyd MR (1994) Circulins A and B. Novel human immunodeficiency virus (HIV)-inhibitory macrocyclic peptides from the tropical tree Chassalia Parvifolia. J Am Chem Soc 116(20):9337\u20139338","DOI":"10.1021\/ja00099a064"},{"issue":"1","key":"10188_CR51","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1006\/jmbi.1998.2276","volume":"285","author":"NL Daly","year":"1999","unstructured":"Daly NL, Koltay A, Gustafson KR, Boyd MR, Casas-Finet JR, Craik DJ (1999) Solution structure by NMR of circulin A: a macrocyclic knotted peptide having anti-HIV activity. J Mol Biol 285(1):333\u2013345","journal-title":"J Mol Biol"},{"key":"10188_CR52","doi-asserted-by":"crossref","unstructured":"Hallock YF, Sowder RC 2nd, Pannell LK, Hughes CB, Johnson DG, Gulakowski R, Cardellina JH 2nd, Boyd MR (2000) Cycloviolins A-D, anti-HIV macrocyclic peptides from Leonia cymosa. J Org Chem 65(1):124\u2013128","DOI":"10.1021\/jo990952r"},{"key":"10188_CR53","unstructured":"Schoepke T, Hasan Agha M, Kraft R, Otto A (1993) Compounds with hemolytic activity from Viola tricolor L. and Viola arvensis Murray. Sci Pharm 61:145\u2013145"},{"issue":"1","key":"10188_CR54","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1021\/np050317i","volume":"69","author":"B Chen","year":"2006","unstructured":"Chen B, Colgrave ML, Wang C, Craik DJ (2006) Cycloviolacin H4, a hydrophobic cyclotide from Viola Hederaceae. J Nat Prod 69(1):23\u201328","journal-title":"J Nat Prod"},{"issue":"9","key":"10188_CR55","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.4155\/fmc.09.129","volume":"1","author":"NL Daly","year":"2009","unstructured":"Daly NL, Craik DJ (2009) Design and therapeutic applications of cyclotides. Future Med Chem 1(9):1613\u20131622","journal-title":"Future Med Chem"},{"issue":"3","key":"10188_CR56","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1517\/17460441.2012.661554","volume":"7","author":"DJ Craik","year":"2012","unstructured":"Craik DJ, Swedberg JE, Mylne JS, Cemazar M (2012) Cyclotides as a basis for drug design. Expert Opin Drug Discov 7(3):179\u2013194","journal-title":"Expert Opin Drug Discov"},{"issue":"2","key":"10188_CR57","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1021\/np200722w","volume":"75","author":"C Gr\u00fcndemann","year":"2012","unstructured":"Gr\u00fcndemann C, Koehbach J, Huber R, Gruber CW (2012) Do plant cyclotides have potential as immunosuppressant peptides? J Nat Prod 75(2):167\u2013174","journal-title":"J Nat Prod"},{"issue":"6","key":"10188_CR58","doi-asserted-by":"publisher","first-page":"e68016","DOI":"10.1371\/journal.pone.0068016","volume":"8","author":"C Gr\u00fcndemann","year":"2013","unstructured":"Gr\u00fcndemann C, Thell K, Lengen K, Garcia-K\u00e4ufer M, Huang Y-H, Huber R, Craik DJ, Schabbauer G, Gruber CW (2013) Cyclotides suppress human T-lymphocyte proliferation by an interleukin 2-dependent mechanism. PLoS ONE 8(6):e68016","journal-title":"PLoS ONE"},{"issue":"14","key":"10188_CR59","doi-asserted-by":"publisher","first-page":"10797","DOI":"10.1074\/jbc.M109.089854","volume":"285","author":"YH Huang","year":"2010","unstructured":"Huang YH, Colgrave ML, Clark RJ, Kotze AC, Craik DJ (2010) Lysine-scanning mutagenesis reveals an amendable face of the cyclotide kalata B1 for the optimization of nematocidal activity. J Biol Chem 285(14):10797\u201310805","journal-title":"J Biol Chem"},{"issue":"15","key":"10188_CR60","doi-asserted-by":"publisher","first-page":"9805","DOI":"10.1074\/jbc.M709303200","volume":"283","author":"SM Simonsen","year":"2008","unstructured":"Simonsen SM, Sando L, Rosengren KJ, Wang CK, Colgrave ML, Daly NL, Craik DJ (2008) Alanine scanning mutagenesis of the prototypic cyclotide reveals a cluster of residues essential for bioactivity. J Biol Chem 283(15):9805\u20139813","journal-title":"J Biol Chem"},{"issue":"15","key":"10188_CR61","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.1073\/pnas.1519960113","volume":"113","author":"K Thell","year":"2016","unstructured":"Thell K, Hellinger R, Sahin E, Michenthaler P, Gold-Binder M, Haider T, Kuttke M, Liutkevi\u010di\u016bt\u0117 Z, G\u00f6ransson U, Gr\u00fcndemann C, Schabbauer G, Gruber CW (2016) Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis. Proc Natl Acad Sci U S A 113(15):3960\u20133965","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10188_CR62","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10989-018-9701-1","volume":"25","author":"C Gr\u00fcndemann","year":"2019","unstructured":"Gr\u00fcndemann C, Stenberg KG, Gruber CW (2019) T20K: an immunomodulatory cyclotide on its way to the clinic. Int J Pept Res Ther 25(1):9\u201313","journal-title":"Int J Pept Res Ther"},{"key":"10188_CR63","doi-asserted-by":"crossref","unstructured":"Jackson MA, Xie J, Nguyen LTT, Wang X, Yap K, Harvey PJ, Gilding EK, Craik DJ (2023) Plant-based production of an orally active cyclotide for the treatment of multiple sclerosis. Transgenic Res","DOI":"10.1007\/s11248-023-00341-1"},{"issue":"1","key":"10188_CR64","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1021\/cb400548s","volume":"9","author":"CK Wang","year":"2014","unstructured":"Wang CK, Gruber CW, Cemazar M, Siatskas C, Tagore P, Payne N, Sun G, Wang S, Bernard CC, Craik DJ (2014) Molecular grafting onto a stable framework yields novel cyclic peptides for the treatment of multiple sclerosis. ACS Chem Biol 9(1):156\u2013163","journal-title":"ACS Chem Biol"},{"key":"10188_CR65","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1039\/b607324g","volume":"27","author":"P Thongyoo","year":"2006","unstructured":"Thongyoo P, Tate E, Leatherbarrow R (2006) Total synthesis of the macrocyclic cysteine knot microprotein MCoTI-II. Chem comm 27:2848\u20132850","journal-title":"Chem comm"},{"key":"10188_CR66","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1600-065X.2007.00509.x","volume":"217","author":"GH Caughey","year":"2007","unstructured":"Caughey GH (2007) Mast cell tryptases and chymases in inflammation and host defense. Immunol Rev 217:141\u2013154","journal-title":"Immunol Rev"},{"issue":"29","key":"10188_CR67","doi-asserted-by":"publisher","first-page":"20785","DOI":"10.1074\/jbc.R700017200","volume":"282","author":"HP McNeil","year":"2007","unstructured":"McNeil HP, Adachi R, Stevens RL (2007) Mast cell-restricted tryptases: structure and function in inflammation and pathogen defense *. J Biol Chem 282(29):20785\u201320789","journal-title":"J Biol Chem"},{"issue":"1","key":"10188_CR68","doi-asserted-by":"publisher","first-page":"647","DOI":"10.4049\/jimmunol.182.1.647","volume":"182","author":"K Shin","year":"2009","unstructured":"Shin K, Nigrovic PA, Crish J, Boilard E, McNeil HP, Larabee KS, Adachi R, Gurish MF, Gobezie R, Stevens RL, Lee DM (2009) Mast cells contribute to autoimmune inflammatory arthritis via their tryptase\/heparin complexes. J Immunol 182(1):647\u2013656","journal-title":"J Immunol"},{"issue":"20","key":"10188_CR69","doi-asserted-by":"publisher","first-page":"6197","DOI":"10.1021\/jm901233u","volume":"52","author":"P Thongyoo","year":"2009","unstructured":"Thongyoo P, Bonomelli C, Leatherbarrow RJ, Tate EW (2009) Potent inhibitors of \u03b2-tryptase and human leukocyte elastase based on the MCoTI-II scaffold. J Med Chem 52(20):6197\u20136200","journal-title":"J Med Chem"},{"issue":"1","key":"10188_CR70","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jmb.2009.10.028","volume":"395","author":"CP Sommerhoff","year":"2010","unstructured":"Sommerhoff CP, Avrutina O, Schmoldt H-U, Gabrijelcic-Geiger D, Diederichsen U, Kolmar H (2010) Engineered cystine knot miniproteins as potent inhibitors of human mast cell tryptase \u03b2. J Mol Biol 395(1):167\u2013175","journal-title":"J Mol Biol"},{"issue":"3","key":"10188_CR71","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/0014-5793(94)01225-3","volume":"355","author":"P M\u00fchlhahn","year":"1994","unstructured":"M\u00fchlhahn P, Czisch M, Morenweiser R, Habermann B, Engh RA, Sommerhoff CP, Auerswald EA, Holak TA (1994) Structure of leech derived tryptase inhibitor (LDTI-C) in solution. FEBS Lett 355(3):290\u2013296","journal-title":"FEBS Lett"},{"issue":"32","key":"10188_CR72","doi-asserted-by":"publisher","first-page":"19931","DOI":"10.1074\/jbc.272.32.19931","volume":"272","author":"MT Stubbs","year":"1997","unstructured":"Stubbs MT, Morenweiser R, St\u00fcrzebecher J, Bauer M, Bode W, Huber R, Piechottka GP, Matschiner G, Sommerhoff CP, Fritz H, Auerswald EA (1997) The three-dimensional structure of recombinant leech-derived tryptase inhibitor in complex with trypsin: implications for the structure of human mast cell tryptase and its inhibition*. J Biol Chem 272(32):19931\u201319937","journal-title":"J Biol Chem"},{"issue":"10","key":"10188_CR73","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1515\/bchm3.1994.375.10.685","volume":"375","author":"CP Sommerhoff","year":"1994","unstructured":"Sommerhoff CP, S\u00f6llner C, Mentele R, Piechottka GP, Auerswald EA, Fritz H (1994) A Kazal-type inhibitor of human mast cell tryptase: isolation from the medical leech Hirudo medicinalis, characterization, and sequence analysis. Biol Chem Hoppe-Seyler 375(10):685\u2013694","journal-title":"Biol Chem Hoppe-Seyler"},{"key":"10188_CR74","doi-asserted-by":"crossref","unstructured":"Amenta R, Camarda L, Di Stefano V, Lentini F, Venza F (2000) Traditional medicine as a source of new therapeutic agents against psoriasis. Fitoterapia 71 Suppl 1 S13\u201320","DOI":"10.1016\/S0367-326X(00)00172-6"},{"issue":"1","key":"10188_CR75","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jep.2013.10.044","volume":"151","author":"R Hellinger","year":"2014","unstructured":"Hellinger R, Koehbach J, Fedchuk H, Sauer B, Huber R, Gruber CW, Gr\u00fcndemann C (2014) Immunosuppressive activity of an aqueous Viola tricolor herbal extract. J Ethnopharmacol 151(1):299\u2013306","journal-title":"J Ethnopharmacol"},{"issue":"15","key":"10188_CR76","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1055\/a-2173-8627","volume":"89","author":"B Retzl","year":"2023","unstructured":"Retzl B, Zimmermann-Klemd AM, Winker M, Nicolay S, Gr\u00fcndemann C, Gruber CW (2023) Exploring immune modulatory effects of cyclotide-enriched Viola tricolor preparations. Planta Med 89(15):1493\u20131504","journal-title":"Planta Med"},{"key":"10188_CR77","doi-asserted-by":"publisher","first-page":"103958","DOI":"10.1016\/j.msard.2022.103958","volume":"64","author":"L Dayani","year":"2022","unstructured":"Dayani L, Dinani MS, Aliomrani M, Hashempour H, Varshosaz J, Taheri A (2022) Immunomodulatory effects of cyclotides isolated from Viola odorata in an experimental autoimmune encephalomyelitis animal model of multiple sclerosis. Mult Scler Relat Disord 64:103958","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"10188_CR78","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","volume":"164","author":"CS Constantinescu","year":"2011","unstructured":"Constantinescu CS, Farooqi N, O\u2019Brien K, Gran B (2011) Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol 164(4):1079\u20131106","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10188_CR79","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S1044-7431(03)00218-5","volume":"24","author":"T Ben-Hur","year":"2003","unstructured":"Ben-Hur T, Ben-Menachem O, Furer V, Einstein O, Mizrachi-Kol R, Grigoriadis N (2003) Effects of proinflammatory cytokines on the growth, fate, and motility of multipotential neural precursor cells. Mol Cell Neurosci 24(3):623\u2013631","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"10188_CR80","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1471-2377-12-95","volume":"12","author":"C Oreja-Guevara","year":"2012","unstructured":"Oreja-Guevara C, Ramos-Cejudo J, Aroeira LS, Chamorro B, Diez-Tejedor E (2012) TH1\/TH2 cytokine profile in relapsing-remitting multiple sclerosis patients treated with glatiramer acetate or Natalizumab. BMC Neurol 12(1):95","journal-title":"BMC Neurol"},{"key":"10188_CR81","volume-title":"Handbuch phytotherapie: indikationen-anwendungen-wirksamkeit-pr\u00e4parate","author":"C J\u00e4nicke","year":"2003","unstructured":"J\u00e4nicke C, Gr\u00fcnwald J, Brendler T (2003) Handbuch phytotherapie: indikationen-anwendungen-wirksamkeit-pr\u00e4parate. WVG, Wissenschaftliche Verlagsgesellschaft"},{"issue":"03","key":"10188_CR82","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1055\/s-0028-1099776","volume":"18","author":"MS Habib","year":"1970","unstructured":"Habib MS, Harkiss KJ (1970) Quantitative determination of emetine and cepha\u00ebline in ipecacuanha root and its preparations. Planta Med 18(03):270\u2013274","journal-title":"Planta Med"},{"issue":"5","key":"10188_CR83","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/bip.22328","volume":"100","author":"J Koehbach","year":"2013","unstructured":"Koehbach J, Attah AF, Berger A, Hellinger R, Kutchan TM, Carpenter EJ, Rolf M, Sonibare MA, Moody JO, Wong GK-S, Dessein S, Greger H, Gruber CW (2013) Cyclotide discovery in Gentianales revisited\u2014identification and characterization of cyclic cystine-knot peptides and their phylogenetic distribution in Rubiaceae plants. Pep Sci 100(5):438\u2013452","journal-title":"Pep Sci"},{"key":"10188_CR84","doi-asserted-by":"publisher","first-page":"113120","DOI":"10.1016\/j.biopha.2022.113120","volume":"152","author":"CM Falanga","year":"2022","unstructured":"Falanga CM, Steinborn C, Muratspahi\u0107 E, Zimmermann-Klemd AM, Winker M, Krenn L, Huber R, Gruber CW, Gr\u00fcndemann C (2022) Ipecac root extracts and isolated circular peptides differentially suppress inflammatory immune response characterised by proliferation, activation and degranulation capacity of human lymphocytes in vitro. Biomed Pharmacother 152:113120","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10188_CR85","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1021\/acs.jnatprod.0c01069","volume":"84","author":"MEF Pinto","year":"2021","unstructured":"Pinto MEF, Chan LY, Koehbach J, Devi S, Gr\u00fcndemann C, Gruber CW, Gomes M, Bolzani VS, Cilli EM, Craik DJ (2021) Cyclotides from Brazilian Palicourea sessilis and their effects on human lymphocytes. J Nat Prod 84(1):81\u201390","journal-title":"J Nat Prod"}],"container-title":["The Protein Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10930-024-10188-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10930-024-10188-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10930-024-10188-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T17:07:29Z","timestamp":1714410449000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10930-024-10188-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,15]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10188"],"URL":"https:\/\/doi.org\/10.1007\/s10930-024-10188-y","relation":{},"ISSN":["1572-3887","1875-8355"],"issn-type":[{"value":"1572-3887","type":"print"},{"value":"1875-8355","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,15]]},"assertion":[{"value":"26 February 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No potential conflict of interest was reported by the authors. We declared no use of Generative AI and AI-assisted technologies in the writing process.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}